ArticleIndian journal of surgical oncology2025
Role of Radiation Therapy in the Management of Locally Advanced Vulvar Cancer-15 Years of Experience at a Tertiary Care Center in Southern India.
Article in Indian journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vulvar carcinoma represents 3-5% of all gynecological malignancies and 1% of female cancers. Primary surgical excision is the cornerstone of treatment for early-stage invasive disease. Adjuvant radiation therapy reduces the risk of local recurrence in patients with high-risk features, and radical chemoradiation is an option for locally advanced vulvar cancer. This retrospective study aimed to analyze the clinical presentation, treatment details, outcomes, patterns of failure, and possible prognostic factors. We reviewed the electronic medical records of 53 patients diagnosed with carcinoma of the vulva from January 2005 to December 2020. All patients with biopsy-proven carcinoma of the vulva who received radiation therapy with or without surgery were included in the study. The median age at presentation was 59 years (range 35-85 years). The most common stage at presentation was Stage III (37.7%,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.